This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

Blood & Cancer

By Medscape Professional Network

A twice-weekly podcast bringing you news from MDedge Hematology-Oncology on Tuesdays and interviews with hem/onc experts on Thursdays.

  1. 1.
    Choosing surgery for older breast cancer patients, delayed screening from COVID-19 could increase deaths, and blood group O linked to decreased SARS-CoV-2 risk10/20/2020
    10:41
  2. 2.
    TERAVOLT registry sheds light on characteristics, treatment, and outcomes of patients with thoracic cancers and COVID-1910/15/2020
    20:28
  3. 3.
    FDA approves combo immunotherapy for mesothelioma, atezolizumab strikes out in ovarian cancer, and more10/13/2020
    11:29
  4. 4.
    The psychiatry of cancer, a crossover from the Psychcast10/08/2020
    29:00
  5. 5.
    Global stomach cancer deaths decline but colorectal cancer deaths stagnate; plus, divergent results for paclitaxel/nab-paclitaxel for triple negative breast cancer10/06/2020
    11:06
  6. 6.
    ESMO 2020: Late-breaking and practice-changing studies on COVID-19 and breast, lung, gastrointestinal, and other cancers10/01/2020
    59:18
  7. 7.
    Hem-Onc News: No benefit from postop radiotherapy in NSCLC, sotorasib is a 'triumph of drug discovery,' and choosing a TKI for ALL09/29/2020
    13:37
  8. 8.
    Studying cancer patients with COVID-19: Dr. Brian Rini describes the NCCAPS and CCC19 studies and reviews the latest findings09/24/2020
    22:59
  1. 9.
    Waist size and prostate cancer death, AI is on par with radiologists for mammograms, and "How I Treat" MDS from ASH Hematologic Malignancies09/22/2020
    13:46
  2. 10.
    Medical school in the COVID era: Two RCSI students explain how the pandemic has affected them09/17/2020
    29:41
  3. 11.
    Gene testing for all breast cancer patients with second primary malignancy, atezolizumab for TNBC, pralsetinib for NSCLC, and more09/15/2020
    11:56
  4. 12.
    How I treat MDS: Dr. Shannon McCurdy talks prognostic scoring, ESAs, HMAs, transplant, and more09/10/2020
    31:32
  5. 13.
    Hem-Onc News: Delaying radiotherapy for high-risk prostate cancer; melanoma experts say 'no' to routine gene profile testing09/08/2020
    11:57
  6. 14.
    Best of the 2020 American Society of Clinical Oncology Annual Meeting09/03/2020
    27:20
  7. 15.
    Hem-Onc News: Aspirin linked to cancer progression in older adults, inhibitor could 'alter landscape' of RET+ tumors, and Black-White gap closing09/01/2020
    14:47
  8. 16.
    SECURE-SCD: A registry of patients with sickle cell disease and COVID-1908/27/2020
    20:06
  9. 17.
    Diabetes + weight loss could mean a higher risk of pancreatic cancer, digital breast tomosynthesis vs digital mammography, and adjuvant chemo is beneficial for some with low-grade glioma08/25/2020
    9:02
  10. 18.
    Mason Plumlee: NBA star in the Orlando bubble, medical entrepreneur, and COVID-19 survivor08/20/2020
    22:09
  11. 19.
    Hem Onc News: Chemo-free treatment of mesothelioma, FDA approves liquid biopsy for NSCLC, and swallowable device for esophageal cancer08/18/2020
    13:40
  12. 20.
    ISTH 2020: Dr. Hanny Al-Samkari talks VTE in COVID-19, bevacizumab in HHT, and predisposition to thrombosis in NSCLC08/13/2020
    32:41
  13. 21.
    Immunotherapy doesn't impact COVID mortality, breast cancer screening for the developing world, and 2 FDA approvals08/11/2020
    12:55
  14. 22.
    How I treat multiple myeloma: Dr. Gustavo Fonseca talks triple-agent therapy, transplant, and treatment failure08/06/2020
    31:17
  15. 23.
    News from EAU20, ISTH, and AACR's COVID-19 & Cancer meeting: Surgery in renal cell cancer, bevacizumab in HHT, and nosocomial COVID-1908/04/2020
    10:38
  16. 24.
    Beyond the lungs: How COVID-19 affects the blood, brain, gastrointestinal system, and other organ systems07/30/2020
    37:01
  17. 25.
    RTL 03 - HemOnc News: New 'gold standard' for prostate cancer screening, pandemic could increase cancer deaths, genetic testing for early cancers07/28/2020
    12:42
  18. 26.
    Hematology|Oncology Journal Club 01 - All about breast cancer: Lumpectomy margins, partial vs whole breast irradiation, locoregional management after neoadjuvant chemo07/23/2020
    24:46
  19. 27.
    RTL 02 -- The latest news from MDedge Hematology/Oncology: MRI IDs significant prostate cancer, drug interactions to avoid in GI cancers, ctDNA clearance tracks with NSCLC survival, COVID symptoms persist07/21/2020
    12:30
  20. 28.
    Cancer and diet: Dr. Dawn Lemanne describes how fasting can suppress the immune system and lower IGF-1 and blood sugar levels07/16/2020
    23:38
  21. 29.
    Introducing Run the List: the latest hem onc news - Earlier lung screening doubles eligibility, lifestyle reduces breast cancer risk regardless of genetics, FDA approves MDS/CMML drug, COVID mask exemptions07/14/2020
    11:28
  22. 30.
    Personal and professional impact of COVID-19 - diary of an oncologist and vacation on the shore07/09/2020
    19:33
  23. 31.
    Patient anxiety, social support, optimism bias, and 'How long do I have left?': The best-of Dr. Ilana Yurkiewicz07/02/2020
    29:44
  24. 32.
    EHA25: AML, myeloma, polycythemia vera, and COVID-19 with EHA President John Gribben06/25/2020
    28:51
  25. 33.
    Drugs FDA-approved for hematology / oncology in 2020: ‘Game-changing’ and ‘niche’ indications06/18/2020
    29:42
  26. 34.
    ASCO 2020: Practice-changing studies in breast, lung, colorectal, and other cancers06/11/2020
    42:02
  27. 35.
    Non–small cell lung cancer: How to choose the best therapy and reviewing the first virtual ASCO06/04/2020
    35:35
  28. 36.
    Would you choose oncology again? Plus, breast cancer research: HER2CLIMB, KEYNOTE 522, and DESTINY BREAST01 with Dr. Bill Gradishar 05/28/2020
    27:25
  29. 37.
    VTE rate, "COVID toes," and Virchow's triad: What you need to know about COVID and coagulation05/21/2020
    33:56
  30. 38.
    Curbsiders Host Dr. Matt Watto on being an internist in the COVID-19 pandemic05/14/2020
    32:34
  31. 39.
    Treating genitourinary malignancies in the COVID-19 era05/07/2020
    35:21
  32. 40.
    The first virtual ASCO meeting; plus Part 2 of tech tools for docs04/30/2020
    37:12
  33. 41.
    Treating colorectal cancer in the COVID-19 era04/23/2020
    40:30
  34. 42.
    COVID-19 and the community oncologist04/16/2020
    38:53
  35. 43.
    COVID-19 and lung cancer: The decision to delay treatment04/09/2020
    33:37
  36. 44.
    Bonus: COVID-19 critical-care lessons from Seattle04/07/2020
    26:36
  37. 45.
    COVID-19: ‘The world has changed’04/02/2020
    31:02
  38. 46.
    Grands rounds in the age of COVID-19; cardiotoxicity in breast cancer03/26/2020
    32:07
  39. 47.
    Tech tools for docs: Apps, sites, and software in the virtual world03/19/2020
    32:38
  40. 48.
    Common bleeding and coagulation issues03/12/2020
    31:33
  41. 49.
    Is this a good study? The statistics tell the story03/05/2020
    31:53
  42. 50.
    Treatment approaches in AML02/27/2020
    32:53
  43. 51.
    Treatment tips in CLL02/20/2020
    23:11
  44. 52.
    When to refer for CAR T-cell therapy02/13/2020
    21:07
  45. 53.
    Understanding biosimilars02/06/2020
    19:30
  46. 54.
    ASH19 special report01/30/2020
    30:33
  47. 55.
    Sickle cell update: Treating pain and progress toward cure01/23/2020
    25:43
  48. 56.
    Practice-changing research in GI cancer01/16/2020
    26:03
  49. 57.
    Palliative care: Not just another word for hospice01/09/2020
    34:41
  50. 58.
    The best of Clinical Correlation01/02/2020
    15:51
  51. 59.
    ICYMI: Get to know Dr. Ilana Yurkiewicz12/26/2019
    36:03
  52. 60.
    ASCO president on uniting the oncology field  12/19/2019
    22:19
  53. 61.
    2019 drug approvals in hematology-oncology  12/12/2019
    21:20
  54. 62.
    ASH 2019 Preview: Potentially practice-changing studies12/05/2019
    39:40
  55. 63.
    Breaking down biosimilars: ICYMI11/28/2019
    28:08
  56. 64.
    Breast cancer case review with Dr. Jame Abraham11/21/2019
    31:03
  57. 65.
    Immunotherapy in lung cancer with Dr. Jack West, Part 211/14/2019
    30:03
  58. 66.
    Immunotherapy in lung cancer with Dr. Jack West, Part 111/07/2019
    30:53
  59. 67.
    Reader beware: Interpreting post hoc analyses10/31/2019
    23:46
  60. 68.
    Delivering bad news to patients10/24/2019
    28:07
  61. 69.
    Choosing a melanoma therapy with Dr. Justine Cohen10/17/2019
    31:34
  62. 70.
    'What would you do if this were your family member?'10/10/2019
    26:02
  63. 71.
    Ending curative therapy even when the family wants it10/03/2019
    19:42
  64. 72.
    'How long do I have left?' Difficult conversations for trainees (part 1)09/26/2019
    22:30
  65. 73.
    Updated ASCO guidelines for VTE in cancer09/19/2019
    33:56
  66. 74.
    Castleman disease: Dr. David Fajgenbaum chases his cure09/12/2019
    38:20
  67. 75.
    Decoding the mystery of the meta-analysis09/05/2019
    31:40
  68. 76.
    GI malignancy case review08/29/2019
    31:07
  69. 77.
    ASCO 2019 Breast Cancer Update08/22/2019
    34:26
  70. 78.
    Geriatric oncology08/15/2019
    35:17
  71. 79.
    The pitfalls of P values08/08/2019
    31:14
  72. 80.
    Cancer trials in the community08/01/2019
    37:07
  73. 81.
    Polypharmacy in older cancer patients07/25/2019
    33:24
  74. 82.
    Pancreatic cancer and clinical trials07/17/2019
    25:30
  75. 83.
    Financial toxicity of cancer; the illusion of treatment options07/11/2019
    25:25
  76. 84.
    Emergency Oncology: ICYMI07/05/2019
    27:10
  77. 85.
    Bloodless medicine, iron deficiency, and ASCO reflections06/27/2019
    22:32
  78. 86.
    ASCO 2019 Special06/22/2019
    39:05
  79. 87.
    Welcome to Cancerland with David Scadden, MD06/20/2019
    40:09
  80. 88.
    Patient-reported outcomes in cancer06/13/2019
    31:47
  81. 89.
    Ask about constipation, calling patients in the middle of the night06/06/2019
    35:39
  82. 90.
    BONUS: Get to know Ilana Yurkiewicz, MD06/04/2019
    36:29
  83. 91.
    Cancer-related fatigue05/30/2019
    33:40
  84. 92.
    Hazard ratio? P value?05/23/2019
    27:30
  85. 93.
    Lung cancer: PD, PDL-1, and immunotherapy05/16/2019
    35:47
  86. 94.
    ITP: When and how, pregnant patients05/09/2019
    31:56
  87. 95.
    CAR T-cell therapy: Development to access05/02/2019
    33:00
  88. 96.
    ASCO GI 201904/25/2019
    21:58
  89. 97.
    Drug development stats and research04/18/2019
    26:44
  90. 98.
    Anemia in cancer04/11/2019
    27:53
  91. 99.
    Breast Cancer, CDK4/6 Inhibitors04/04/2019
    30:28
  92. 100.
    Sickle Cell Treatment, Part II03/28/2019
    18:27
  93. 101.
    Sickle Cell Treatment, Part I:03/21/2019
    26:03
  94. 102.
    Lymphoma in patients w/ HIV03/14/2019
    24:56
  95. 103.
    Anticoagulation in cancer03/07/2019
    31:06
  96. 104.
    KATHERINE trial and breast cancer02/28/2019
    26:04
  97. 105.
    How to read and review scientific papers02/21/2019
    21:01
  98. 106.
    ESMO 2018 and more02/14/2019
    24:11
  99. 107.
    Biosimilars: Gary Lyman02/07/2019
    30:17
  100. 108.
    Antiemetics: Richard Gralla01/31/2019
    27:28
  101. 109.
    The JCSO Interview: Dr. Maura Sammon08/07/2018
    18:15
  102. 110.
    David Henry’s JCSO podcast, May - June 201808/03/2018
    15:26
  103. 111.
    David Henry’s JCSO podcast, March - April 201808/01/2018
    12:54
  104. 112.
    JCSO Interview with Dr Daniel Haller03/29/2018
    26:40
  105. 113.
    JCSO Interview with Dr. Kenneth Anderson03/27/2018
    31:51
  106. 114.
    JSCO Podcast January - February 201803/23/2018
    15:58

Listen to Blood & Cancer now.

Listen to Blood & Cancer in full in the Spotify app